Increasing incidence of anogenital warts with an urban-rural divide among males in Manitoba, Canada, 1990-2011

BMC Public Health

Volumn 16, Issue 1, 2016, Pages

  Thompson, Laura H ^a,b   Nugent, Zoann ^b   Blanchard, James F ^b   Ens, Carla ^a,b   Yu, Bo Nancy ^a,b  

^a Manitoba Health   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Anogenital conditions; Anogenital warts; Epidemiology; Human papillomavirus; Manitoba

Indexed keywords

ADOLESCENT; ADULT; CHILD; CONDYLOMATA ACUMINATA; FACTUAL DATABASE; FEMALE; HEALTH DISPARITY; HUMAN; INCIDENCE; INFANT; MALE; MANITOBA; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; RURAL HEALTH; STATISTICS AND NUMERICAL DATA; URBAN HEALTH; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CONDYLOMATA ACUMINATA; DATABASES, FACTUAL; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MANITOBA; MIDDLE AGED; RURAL HEALTH; URBAN HEALTH; YOUNG ADULT;

EID: 85007477331     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-016-2885-4     Document Type: Article

References (43)

1. Gross G, Pfister H. Role of human papillomavirus in penile cancer, penile intraepithelial squamous cell neoplasias and in genital warts. Med Microbiol Immunol. 2004;193(1):35-44.
2. Franco EL, Villa LL, Sobrinho JP, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis. 1999;180(5):1415-23.
3. Greer CE, Wheeler CM, Ladner MB, et al. Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts. J Clin Microbiol. 1995;33(8):2058-63.
4. Castellsague X, Ghaffari A, Daniel RW, Bosch FX, Munoz N, Shah KV. Prevalence of penile human papillomavirus DNA in husbands of women with and without cervical neoplasia: A study in Spain and Colombia. J Infect Dis. 1997;176(2):353-61.
5. Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. 2006;55(Rr-11):1-94.
6. Marra F, Ogilvie G, Colley L, Kliewer E, Marra CA. Epidemiology and costs associated with genital warts in Canada. Sex Transm Infect. 2009;85(2):111-5.
7. Patel H, Wagner M, Singhal P, Kothari S. Systematic review of the incidence and prevalence of genital warts. BMC Infect Dis. 2013;13:39.
8. Kliewer EV, Demers AA, Elliott L, Lotocki R, Butler JRG, Brisson M. Twentyyear trends in the incidence and prevalence of diagnosed anogenital warts in canada. Sex Transm Dis. 2009;36(6):380-6.
9. Manitoba Health HLaS. Human Papillomavirus (HPV) Information for Health Professionals. 2013.
10. Manitoba Health HLaS. Manitoba's Immunication Program: Vaccines Offered Free-of-Charge (Eligibility Criteria for Pbulicly-Funded Vaccines). http://www.gov.mb.ca/health/publichealth/cdc/vaccineeligibility.html. Online accessed Jan 12, 2016. 2015.
11. Statistics-Canada. Census Profile. 2014.
12. Booth GL, Hux JE. Relationship between avoidable hospitalizations for diabetes mellitus and income level. Arch Intern Med. 2003;163(1):101-6.
13. Lipscombe LL, Austin PC, Manuel DG, Shah BR, Hux JE, Booth GL. Incomerelated differences in mortality among people with diabetes mellitus. CMAJ. 2010;182(1):E1-e17.
14. Marrie RA, Elliott L, Marriott J, et al. Dramatically changing rates and reasons for hospitalization in multiple sclerosis. Neurology. 2014;83(10):929-37.
15. Booth GLHJ. Relationship between avoidable hospitalizatins for diabetes mellitus and income level. Arch Intern Med. 2003;163:6.
16. Chen HS, Portier K, Ghosh K, et al. Predicting US-And state-level cancer counts for the current calendar year: Part I: Evaluation of temporal projection methods for mortality. Cancer. 2012;118(4):1091-9.
17. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335-51.
18. Kim HJ, Luo J, Kim J, Chen HS, Feuer EJ. Clustering of trend data using joinpoint regression models. Stat Med. 2014;33(23):4087-103.
19. Steben M, Ouhoummane N, Rodier C, Brassard P. Temporal trends in genital warts among individuals covered by the public prescription drug insurance plan in the province of Quebec, Canada, from 1998 to 2007. Journal of lower genital tract disease. 2013;17(2):147-53.
20. Beltrami JF, Shouse RL, Blake PA. Trends in infectious diseases and the male to female ratio: possible clues to changes in behavior among men who have sex with men. AIDS Educ Prev. 2005;17(6 SupplB):49-59.
21. Canada PHAo. Report on Sexually Transmitted Infections in Canada: 2011. In: Centre for Communicable Diseases and Infection Control, Infectious Disease Prevention and Control Branch, Public Health Agency of Canada. 2014.
22. Fenton KA, Imrie J. Increasing rates of sexually transmitted diseases in homosexual men in Western europe and the United States: Why? Infect Dis Clin North Am Jun. 2005;19(2):311-31.
23. Jayaraman GC, Read RR, Singh A. Characteristics of individuals with male-Tomale and heterosexually acquired infectious syphilis during an outbreak in Calgary, Alberta. Canada Sex Transm Dis. 2003;30(4):315-9.
24. Jiamton S, Leeyaphan C, Maneeprasopchoke P, Omcharoen V. Prevalence and clinical manifestations of male patients with anogenital warts attending a sexually transmitted disease clinic prior Hpv vaccine recommendation. Southeast Asian J Trop Med Public Health. 2014;45(6):1337-43.
25. Mansergh G, Flores S, Koblin B, Hudson S, McKirnan D, Colfax GN. Alcohol and drug use in the context of anal sex and other factors associated with sexually transmitted infections: Results from a multi-city study of high-risk men who have sex with men in the USA. Sex Transm Infect. 2008;84(6):509-11.
26. Mayer KH. Sexually transmitted diseases in men who have sex with men. Clin Infect Dis. 2011;53 Suppl 3:S79-S83.
27. Poon AF, Joy JB, Woods CK, et al. The impact of clinical, demographic and risk factors on rates of HIV transmission: A population-based phylogenetic analysis in British Columbia. Canada J Infect Dis. 2015;211(6):926-35.
28. Steben M, LaBelle D. Genital warts: Canadians' perception, health-related behaviors, and treatment preferences. Journal of lower genital tract disease. 2012;16(4):409-15.
29. Oster AM, Sternberg M, Lansky A, Broz D, Wejnert C, Paz-Bailey G. Population size estimates for Men who have Sex with Men and persons who inject drugs. J Urban Health Aug. 2015;92(4):733-43.
30. Aral SO, Hughes JP, Stoner B, et al. Sexual mixing patterns in the spread of gonococcal and chlamydial infections. Am J Public Health. 1999;89(6):825-33.
31. Aral SO, Ward H. Behavioral convergence: implications for mathematical models of sexually transmitted infection transmission. The Journal of infectious diseases. 2014;210 Suppl 2:S600-S604.
32. Fujimoto K, Williams ML. Racial/ethnic differences in sexual network mixing: A Log-linear analysis of HIV status by partnership and sexual behavior among most at-risk MSM. AIDS Behav. 2015;19(6):996-1004.
33. Poynten IM, Waterboer T, Jin F, et al. Human papillomavirus types 6 and 11 seropositivity: Risk factors and association with ano-genital warts among homosexual men. J Infect Jun. 2013;66(6):503-11.
34. Kraut AA, Schink T, Schulze-Rath R, Mikolajczyk RT, Garbe E. Incidence of anogenital warts in Germany: A population-based cohort study. BMC Infect Dis. 2010;10:360.
35. Sanchez DM, Pathela P, Niccolai LM, Schillinger JA. Knowledge of human papillomavirus and anal cancer among men who have sex with men attending a New York City sexually transmitted diseases clinic. Int J STD AIDS Jan. 2012;23(1):41-3.
36. Nadarzynski T, Smith H, Richardson D, Jones CJ, Llewellyn CD. Human papillomavirus and vaccine-related perceptions among men who have sex with men: A systematic review. Sex Transm Infect. 2014;90(7):515-23.
37. Graham DM, Isaranuwatchai W, Habbous S, et al. A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer. Cancer. 2015;121(11):1785-92.
38. Smith LM, Strumpf EC, Kaufman JS, Lofters A, Schwandt M, Levesque LE. The early benefits of human papillomavirus vaccination on cervical dysplasia and anogenital warts. Pediatrics. 2015;135(5):e1131-e 1140.
39. O'Malley KJ, Cook KF, Price MD, Wildes KR, Hurdle JF, Ashton CM. Measuring diagnoses: ICD code accuracy. Health Serv Res. 2005;40(5 Pt 2):1620-39.
40. Surjan G. Questions on validity of international classification of diseasescoded diagnoses. Int J Med Inform. 1999;54(2):77-95.
41. Roos LL, Gupta S, Soodeen RA, Jebamani L. Data quality in an informationrich environment: Canada as an example. Canadian journal on aging = La revue canadienne du vieillissement Spring . 2005;24 Suppl 1:153-70.
42. Fransoo R, Yogendran M, Olafson K, Ramsey C, McGowan KL, Garland A. Constructing episodes of inpatient care: data infrastructure for populationbased research. BMC Med Res Methodol. 2012;12:133.
43. Beutner KR, Reitano MV, Richwald GA, Wiley DJ. External genital warts: Report of the american medical association consensus conference. AMA expert panel on external genital warts. Clinical infectious diseases : An official publication of the Infectious Diseases Society of America. 1998;27(4): 796-806.